Henry Hagnäs

We are nearing the end of the second wave of the 2009 H1N1 pandemic, and are now a few months out from the release of the vaccine directed against it.  Two topics have dominated the conversation: the safety of the 2009 H1N1 influenza vaccine, and the actual severity of the 2009 H1N1 infection.  Considering the amount of attention SBM has paid the pandemic and its surrounding issues, and in light of a couple of studies just released, it seems time for an update.

Excellent, if not a bit too technical and dry, recap of what is known and what has happened with H1N1 and the vaccine (US-centric). Bottom line is that the vaccine has worked very will with little side-effects and especially if you are in the high-risk group you should get vaccinated before a possible third wave (usual in flu-epidemics).